drugset / Trial / NCT00189436

Effect of Nebulized Budesonide and Oral Corticosteroids on Wheezing Episode Relapse in Children

NCT00189436

Phase 4 Completed 61 enrolled Deborah Gentile AstraZeneca · collab
RandomizedParallel-groupOpen-labelPrevention

Summary

Subjects aged 1-8 years who have been discharged from the emergency department/outpatient care facility with a diagnosis of asthma/bronchospasm/wheezing after usual standard care will be enrolled into this open-label, randomized, parallel-group study to compare the efficacy of nebulized budesonide and oral corticosteroids in preventing asthma exacerbation relapse rates during the 21-day follow-up period.

Timeline

Start
2003-03
Primary completion
2009-01
Completion
2009-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Budesonide Small molecule 0.5 unknown Inhaled
Comparator Salbutamol Unknown

Indications